Armistice Capital, LLC Bicycle Therapeutics PLC Transaction History
Armistice Capital, LLC
- $5.71 Billion
- Q2 2025
A detailed history of Armistice Capital, LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Armistice Capital, LLC holds 2,800,000 shares of BCYC stock, worth $20.2 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
2,800,000
Previous 2,672,000
4.79%
Holding current value
$20.2 Million
Previous $22.7 Million
14.22%
% of portfolio
0.34%
Previous 0.35%
Shares
10 transactions
Others Institutions Holding BCYC
# of Institutions
118Shares Held
42.2MCall Options Held
111KPut Options Held
16.6K-
Baker Bros. Advisors LP New York, NY10.9MShares$78.6 Million0.77% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$24.9 Million6.5% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$19.2 Million0.12% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$14.5 Million0.72% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.77MShares$12.8 Million0.03% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $214M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...